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Summary  30 
The trajectory of IgE levels before, during and after pregnancy in sensitized individuals is 31 
characterized by significant increase in specific IgE to birch allergens but not to other allergens 32 
after multiple testing. This increase may warrant some surveillance in the antenatal care for 33 
those with clinical symptoms. 34 
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To the Editor: 39 
A strong association has been found between IgE reactivity to allergens and asthma, eczema 40 
and rhinitis but these diseases also exist in non-sensitized individuals (1). During pregnancy, IgG, 41 
IgM and IgA have been found to decrease between first and third trimester and to increase 42 
postpartum but the decrease in IgG was mainly due to hemodilution (2). For IgE, studies report 43 
a decrease in total IgE concentration in plasma from pregnancy to after delivery in allergic 44 
mothers (3), however, this decrease was not observed for allergen-specific IgE (asIgE) to 45 
common inhalant allergens (3). In order to tolerate the semiallogeneic fetus a regulated 46 
homeostasis between the Th1/Th2/Th17 (with additional Th9 and Treg) cell subsets and their 47 
dynamic and complex inter-relationship is essential during pregnancy (4, 5)To our knowledge, 48 
no study has included measures of asIgE before conception to study the trajectory of asIgE in 49 
sensitized women. Our aim was to investigate changes of asIgE before, during and after 50 
pregnancy. 51 
In the prospective longitudinal cohort study Born into Life, we followed 106 women during 52 
2010-2013 living in Stockholm before, during and after pregnancy (6). In total 413 blood 53 
samples were collected at baseline (before conception, n=102), at gestational week 10-14 54 
(n=64) and 26-28 (n=93), at admission to hospital (n=74), and 3 days after delivery (n=80).  55 
Plasma from these blood samples at all time-points were analyzed for IgE-reactivity against a 56 
mixture of 11 inhalant allergens, Phadiatop® and 6 food allergens, fx5® (Thermo Fisher 57 
Scientific, Uppsala, Sweden). If the test screened positive for Phadiatop® ≥0.35 kUA/L, asIgE 58 
antibodies to the most common single airborne allergens;cat, dog, horse-epithelium, birch and 59 
4 
 
 
timothy were analysed. We did not include house dust mite allergens, since they are not 60 
abundant in Sweden. If screening positive for fx5® ≥0.35 kUA/L the sample was subsequently 61 
analysed for asIgE antibodies to the single allergens extract of egg, milk, cod, wheat and soy. To 62 
investigate change over time in each specific allergen (as well as all airborne allergens taken 63 
together), a mixed tobit-model was applied. Correction for multiple testing was made by the 64 
Bonferroni method. Since very few women (n=5) tested positive for fx5® we only present 65 
descriptive statistics for these food allergens. Details on study population, data-sources, 66 
variables and statistical analyses are provided in this article’s online supporting information. The 67 
Regional Ethics Review Board in Stockholm, Sweden, granted ethical approval. Written informed 68 
consent was obtained from the study participants.  69 
In total, n=38 women screened positive for Phadiatop®, n=5 women screened positive for fx5®, 70 
n=4 women screened positive for both Phadiatop® and fx5® and n=67 women were negative for 71 
both Phadiatop® and fx5®. See Table E1 for baseline descriptive in this article’s online 72 
supporting information. 73 
Figure 1a and Table E2 in this article’s online supporting information displays the geometric 74 
mean for IgE airborne allergens concentration over time with 95% Confidence Interval (CI). The 75 
highest geometric mean concentration of asIgE for all time points was found for birch. The 76 
geometric mean concentration of IgE to birch was 0.57 (95% CI 0.39-0.83) kUA/L. At baseline, 77 
before conception, the IgE concentration to birch was 0.41 (0.19-0.88) kUA/L and 3 days after 78 
delivery 0.72 (0.31-1.70) kUA/L. The geometric mean concentration of IgE to cat was 0.21 (0.16-79 
0.28) kUA/L, at baseline 0.21 (0.11-0.40) kUA/L and 0.24 (0.09-0.63) kUA/L week 10-14 during 80 
pregnancy. Figure 1b shows the specific food allergens over time with 95% CI where IgE to soy 81 
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displays the highest concentration although low in numbers (max n=5) for all food-allergens, 82 
Table E2.  83 
Table 1 shows results from the multivariate mixed tobit model. Levels of IgE to birch increased 84 
significantly over time, with β=1.006 (95% CI: 1.002-1.010), which means that by one week 85 
progress in pregnancy the IgE geometric mean concentration increased by 0.6%. This remained 86 
significant after correction for multiple testing using Bonferroni, with similar results for those 87 
with at least one test above 0.10 kUA/L. The largest regression coefficient was found when all 88 
airborne allergens were taken together in one analysis, β=1.007, and the smallest was seen for 89 
timothy, β=1.003 however non-significant.  90 
In summary, we report a small but statistically significant increase over time from 91 
preconception to postpartum for asIgE to birch allergen, but no changes for other allergens. This 92 
finding is in line with previous findings that birch-induced cytokine levels were increased during 93 
pregnancy compared to post-partum in sensitized women with allergic symptoms (7). While 94 
they measured Th2-like cytokines and we assessed levels of asIgE, Th2-like cytokines and IgE has 95 
been shown to be related in a series of cellular reactions (5). Th2 cells are suggested to be the 96 
key T-helper cell subset responsible for allergic disease (5), and normal pregnancies have been 97 
described as an adequate balance for Th1/Th2 immunity which is slightly shifted to Th2-type 98 
immunity with additional regulation of the Th17 and Treg cells (4). Thus, the Th2-like immunity 99 
associated with allergic disease could be beneficial for the maintenance of a successful 100 
pregnancy. On the other hand, pregnancy might enhance the already Th2-skewed immunity of 101 
allergic women, expose the foetus to a strong Th2 environment, and perhaps lead to allergy 102 
development later in life (8). Since there is a strong correlation between sensitization and 103 
6 
 
 
allergic symptoms, our findings may warrant some surveillance of allergic women with clinical 104 
symptoms in the antenatal care. 105 
The strength of this study is the longitudinal design with repeated measurements before 106 
conception, during pregnancy and after delivery. In addition, our study population was very 107 
homogeneous regarding age, geography and education. We also controlled for season, which is 108 
particularly important for the specific birch and timothy allergens at this geographical latitude, 109 
and we applied multiple test correction, making type I error less likely. The limitations include a 110 
small cohort size resulting in low statistical power. Normal aging could be an issue, however, 111 
findings from the follow-up by European Community Respiratory Health Survey rather showed 112 
that aging was associated with decreased levels of sensitization (9). Methodological issues 113 
relating to the analyses of biological samples could affect the results although the analyses were 114 
all performed on the same instrument, randomized and using the same batch reagents. 115 
Furthermore, being sensitized to birch is very common in this region and we can not rule out 116 
that there is also an effect for the other allergens, including timothy, although not statistically 117 
significant due to lower power. 118 
In conclusion, we found a small but statistically significant increase in IgE levels to birch 119 
allergens in women over time before, during and after pregnancy but no statistically significant 120 
change in levels of asIgE for other inhalant allergens or food allergens.  121 
 122 
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w = week during pregnancy 180 
3 d = 3 days after delivery 181 
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 182 
Figure 1a-b. IgE-reactivity to airborne (a) and food (b) allergens over time in women pre, 183 
during and post pregnancy, presented as geographic means with 95% Confidence Intervals. 184 
 185 
 186 
 187 
Table 1. Regression coefficients for time from mixed tobit model with 95% Confidence 188 
Intervals. 189 
    All    At least one above 0.10 kUA/L 
Allergen β 95% CI p-value β 95% CI p-value 
Airborne allergens 
(all) 1.007 0.991 1.024 0.388 1.006 0.993 1.020 0.346 
Cat 1.005 0.998 1.012 0.136 1.005 0.998 1.012 0.142 
Horse 1.005 0.998 1.011 0.160 1.005 0.998 1.011 0.170 
Dog 1.004 0.998 1.009 0.208 1.004 0.998 1.009 0.215 
Birch 1.006 1.002 1.010 0.004 1.006 1.002 1.010 0.004 
Timothy 1.003 0.999 1.008 0.143 1.003 0.999 1.008 0.140 
β = Exponentiated regression coefficient for time 
(weeks) from analysis on log-transformed data       
p-value cut-off with Bonferroni correction = 0.008       
        
 190 
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Online Supporting Information  1 
Study Population 2 
Born into Life originates from the larger LifeGene study which has been described in detail 3 
elsewhere (1). In short, LifeGene included index persons between 18-45 years who were also 4 
encouraged to invite their household members. At enrollment each participant was invited to a 5 
test center where biosamples were taken as well as physical measurements. A web-based 6 
questionnaire based on multifaceted questions regarding health, diet, lifestyle and diseases was 7 
administered at baseline and annually thereafter with a shorter version. Women who became 8 
pregnant in LifeGene in Stockholm during 2010-2013 were recruited to Born into Life. The 9 
women answered a web-based questionnaires at gestational week 10-14 and 26-18 regarding 10 
health, diseases, lifestyle and pregnancy.  11 
Blood samples and analyses of IgE-reacivity to allergens 12 
Blood samples from 106 women were collected before conception, at gestational week 10-14 13 
and 26-28, at admission to the hospital for delivery (cord-blood), and 3 days after delivery in 14 
conjunction with the Phenylketonuria screening of the child (2). A positive screening test for 15 
either common inhalant allergens (Phadiatop®) or food allergens (fx5®) is fulfilled if the 16 
concentration is ≥ 0.35 kUA/L. A total of n=155 tests from 38 women screened positive for 17 
Phadiatop® and n=15 tests from 5 women screened positive for fx5®. Based on this information 18 
we selected samples to analyse allergen-specific IgE (asIgE). We selected the samples from 19 
women who screened positive for one test and had at least one other test at another time-point 20 
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(regardless if this test was screened positive or not), in total n=131 tests from 33 women 21 
regarding airborne allergens and n=19 tests from 5 women regarding food allergens. These 22 
specific allergens were reported as continuous values, from <0.10 to >100 kUA/L, i.e. the lower 23 
limit of quantification (LOQ) was 0.10 kUA/L. All samples were analyzed at the Centre for Child 24 
Research, Södersjukhuset, Stockholm, Sweden. 25 
Data sources and variables 26 
Maternal age was retrieved from the medical birth records for each mother and child. Highest 27 
attained educational level (from mandatory secondary school to high school, university or 28 
other) was derived from LifeGene questionnaires.  Educational level was used as a proxy for 29 
socioeconomic status (3). The covariate season of the year was coded as 1, if the sample was 30 
taken during the pollen season of the year in this geographical region (i.e., May-June-July) and 0 31 
otherwise (i.e., all other months). 32 
Statistical analyses 33 
Baseline descriptive statistics included frequencies and percentages for count variables. Chi-34 
squares with Fisher’s exact test were applied to the categorical variables. All data were initially 35 
analyzed for normality and extreme values. Due to positively skewed distribution of the IgE 36 
concentration, the values of the IgE were logarithmically transformed. For the descriptive 37 
statistics, samples less than LOQ (i.e., <0.10 kUA/L) were exchanged with fill values equal to 38 
LOQ/ √2. 39 
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The tobit model is a regression model for truncated data method, analyzing laboratory 40 
measurements subject to detection or quantification limits (i.e., where non-detects are values 41 
below a given detection limit, which may not be observed, in this case from zero to 0.10 kUA/L) 42 
(4). In the mixed tobit model we assume an intercept, αi, for each woman, where αi~N(0, σ2) 43 
and that data are missing at random. Our explanatory variable was time, measured in weeks. 44 
The analyses were adjusted for season (at which season the measurement was taken), since it 45 
has been found that seasonal exposure to pollen influences IgE antibody levels in allergic 46 
individuals (5). For ease of interpretation, the regression coefficients (logβ) and the 47 
corresponding CIs were exponentiated back to the original scale. Thus (1-β)×100 can be 48 
interpreted percentage increase in asIgE geometric mean concentration associated with one 49 
week progression in pregnancy. We first included all data (everyone above the cut-off ≥0.35 50 
kUA/L for Phadiatop® and fx5®) in our analyses and then did sensitivity analyses using subjects 51 
with at least one test above the lower limit of quantification (LOQ) for each specific allergen 52 
(i.e., ≥0.10 kUA/L.) Data management was performed using SAS 9.4 (SAS Institute, Cary, NC, 53 
USA) and data analyses was conducted using STATA/IC 15.0 for Windows (StataCorp LLC, 54 
College Station, TX, USA).  55 
 56 
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Online Supporting Information  
 
Table E1. Baseline descriptive characteristics of the cohort. 
  
Phadiatop® 
negative and fx5® 
negative n=67 
Phadiatop® 
positive 
n=38 (>0.35 
kUA/L) 
fx5® positive 
n=5 (>0.35 
kUA/L) 
Age (years) n(%) n (%) n(%) 
  <19 0 0 0 
  20-24 1 (1.5) 1 (2.6) 0 
  25-29 9 (13.4) 11 (29.0) 1 (20.0) 
  29-34 36 (53.7) 17 (44.7) 2 (40.0) 
>34 21 (31.3) 8 (21.1) 2 (40.0) 
missing 0 1 (2.6) 0 
Education 
(years)       
  <9 0 0 0 
  10-12 4 (6.0) 5 (13.2) 1 (20.0) 
  >13 59 (88.1) 27 (71.1) 3 (60.0) 
other 2 (3.0) 1 (2.6) 1 (20.0) 
missing 2 (3.0) 5 (13.2) 0 
n = nr of participants 
 
 
 
 
 
 
 
Table E2. Quantification of the specific allergens with geometric mean, 95% confidence interval and number of individuals.  
CI=Confidence Interval 
n =number of individuals 
 
Allergen Geometric mean (95% CI) n Baseline   n Week 10-14   n Week 26-28   n 
Admission for 
delivery  n 
3 days after 
delivery  n 
Cat 0.21 (0.16-0.28) 131 0.21 (0.11-0.40) 31 0.24 (0.09-0.63) 17 0.22 (0.12-0.41) 32 0.17 (0.10-0.29) 25 0.21 (0.11-0.40) 26 
Horse 0.13 (0.11-0.16) 131 0.13 (0.08-0.19) 31 0.17 (0.09-0.34) 17 0.13 (0.09-0.19) 32 0.11 (0.08-0.16) 25 0.14 (0.09-0.22) 26 
Dog 0.17 (0.13-0.21) 131 0.15 (0.09-0.25) 31 0.25 (0.11-0.58) 17 0.16 (0.10-0.26) 32 0.14 (0.08-0.24) 25 0.18 (0.10-0.31) 26 
Birch 0.57 (0.39-0.83) 131 0.41 (0.19-0.88) 31 0.78 (0.26-2.38) 17 0.45 (0.21-0.97) 32 0.71 (0.30-1.70) 25 0.72 (0.31-1.70) 26 
Timothy 0.44 (0.32-0.62) 127 0.37 (0.19-0.74) 30 0.40 (0.15-1.05) 17 0.36 (0.19-0.70) 31 0.51 (0.23-1.12) 23 0.63 (0.30-1.35) 26 
             
Egg 0.11 (0.09-0.14) 19 0.14 (0.07-0.26) 5 0.12 (0.07-0.19) 3 0.10 (0.07-0.16) 5 0.09 (0.06-0.15) 3 0.09 (0.06-0.15) 3 
Milk 0.13 (0.09-0.18) 19 0.13 (0.06-0.27) 5 0.16 (0.07-0.36) 3 0.13 (0.06-0.28) 5 0.11 (0.04-0.29) 3 0.10 (0.05-0.23) 3 
Cod 0.07 (0.07-0.07) 19 0.07 (0.07-0.07) 5 0.07 (0.07-0.07) 3 0.07 (0.07-0.07) 5 0.07 (0.07-0.07) 3 0.07 (0.07-0.07) 3 
Wheat 0.25 (0.16-0.39) 19 0.20 (0.08-0.46) 5 0.46 (0.27-0.81) 3 0.23 (0.09-0.60) 5 0.25 (0.06-1.02) 3 0.24 (0.06-1.07) 3 
Soy 0.23 (0.10-0.52) 18 0.19 (0.03-1.36) 4 0.37 (0.04-3.87) 3 0.18 (0.04-0.75) 5 0.25 (0.02-3.15) 3 0.25 (0.02-2.95) 3 
